Telix Pharmaceuticals Ltd
- Last sale
- Nov 12, 2026 · -3.70%
- Market cap
- —
- no share count on file
- Filings
- 109
FY 2025+55.6% FY25 yoy
FY 2025N/M FY25 yoy
FY 2025−46.0% FY25 yoy
FY 2025derivedN/M FY25 yoy
FY 2025N/M FY25 yoy
FY 2025−67.8% FY25 yoy
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $803,794,000 | reported | |
| FY 2024 | 2024-12-31 | $516,551,000 | reported | |
| FY 2023 | 2023-12-31 | $332,978,000 | reported |
Pharmaceutical preparations
Telix Pharmaceuticals Ltd is the 40th largest of the 552 covered companies the SEC files under this code, by revenue. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
IONSIonis Pharmaceuticals Inc$943.7M33.8%40.4%$4.5BANIPANI Pharmaceuticals Inc$883.4M43.8%8.9%$1.6BHRMYHarmony Biosciences Holdings, Inc.$868.5M21.5%18.3%$2.0B
TLXTelix Pharmaceuticals Ltd (this company)$803.8M55.6%0.9%—
COLLCollegium Pharmaceutical, Inc$780.6M23.6%8.1%$776.1MCORTCorcept Therapeutics Inc$761.4M12.8%13.1%$8.1BEBSEmergent BioSolutions Inc.$742.9M28.8%7.1%$302.3MPCRXPacira BioSciences, Inc.$726.4M3.6%1.0%$1.5BAMPHAmphastar Pharmaceuticals, Inc.$719.9M1.7%13.6%$1.2BPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Telix Pharmaceuticals Ltd · CIK 2007191 · Engraved from SEC EDGAR